Clinical Trial Update: Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

A Phase 2 salvage chemotherapy trial using cladribine in relapsed/refractory and high-risk myeloid diseases (acute myeloid leukemia and myelodysplastic syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2026-03-30